1. Adelaide Research & Scholarship

Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 1-10 of 13 (Search time: 0.004 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2016Mycophenolate mofetil is an effective and safe option for the management of systemic sclerosis-associated interstitial lung disease: results from the Australian Scleroderma Cohort studyOwen, C.; Ngian, G.; Elford, K.; Moore, O.; Stevens, W.; Nikpour, M.; Rabusa, C.; Proudman, S.; Roddy, J.; Zochling, J.; Hill, C.; Sturgess, A.; Tymms, K.; Youssef, P.; Sahhar, J.
2014The association of antiphospholipid antibodies with cardiopulmonary manifestations of systemic sclerosisMorrisroe, K.; Stevens, W.; Nandurkar, H.; Prior, D.; Thakkar, V.; Roddy, J.; Zochling, J.; Sahhar, J.; Tymms, K.; Sturgess, A.; Major, G.; Kermeen, F.; Hill, C.; Walker, J.; Nash, P.; Gabbay, E.; Youssef, P.; Proudman, S.; Nikpour, M.
2013Quantifying change in pulmonary function as a prognostic marker in systemic sclerosis-related interstitial lung diseaseMoore, O.; Proudman, S.; Goh, N.; Corte, T.; Rouse, H.; Hennessy, O.; Thakkar, V.; Sahhar, J.; Roddy, J.E.; Youssef, P.; Gabbay, E.; Nash, P.; Zochling, J.; Stevens, W.; Nikpour, M.; 2013 ACR/ARHP Annual Meeting (25 Oct 2013 - 30 Oct 2013 : San Diego, CA)
2012N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control studyThakkar, V.; Stevens, W.; Prior, D.; Moore, O.; Byron, J.; Liew, D.; Patterson, K.; Hissaria, P.; Roddy, J.; Zochling, J.; Sahhar, J.; Nash, P.; Tymms, K.; Celermajer, D.; Gabbay, E.; Youssef, P.; Proudman, S.; Nikpour, M.
2020Incidence, risk factors and outcomes of cancer in systemic sclerosisMorrisroe, K.; Hansen, D.; Huq, M.; Stevens, W.; Sahhar, J.; Ngian, G.-S.; Ferdowsi, N.; Hill, C.; Roddy, J.; Walker, J.; Proudman, S.; Nikpour, M.
2023Clinical characteristics and survival of pulmonary arterial hypertension with or without interstitial lung disease in systemic sclerosis.Fairley, J.L.; Hansen, D.; Ross, L.; Proudman, S.; Sahhar, J.; Ngian, G.-S.; Walker, J.; Host, L.V.; Morrisroe, K.; Apostolopoulous, D.; Ferdowsi, N.; Wilson, M.; Tabesh, M.; Stevens, W.; Nikpour, M.; Australian Scleroderma Interest Group,
2022Evaluation of patient and physician assessments of gastrointestinal disease activity in systemic sclerosisRoss, L.; Proudman, S.; Walker, J.; Stevens, W.; Ferdowsi, N.; Quinlivan, A.; Morrisroe, K.; Baron, M.; Nikpour, M.
2022Gastric antral vascular ectasia in systemic sclerosis: a study of its epidemiology, disease characteristics and impact on survivalMorrisroe, K.; Hansen, D.; Stevens, W.; Sahhar, J.; Ngian, G.S.; Hill, C.; Roddy, J.; Walker, J.; Proudman, S.; Nikpour, M.
2014An immunochip-based interrogation of scleroderma susceptibility variants identifies a novel association at DNASE1L3Zochling, J.; Newell, F.; Charlesworth, J.; Leo, P.; Stankovich, J.; Cortes, A.; Zhou, Y.; Stevens, W.; Sahhar, J.; Roddy, J.; Nash, P.; Tymms, K.; Rischmueller, M.; Lester, S.; Proudman, S.; Brown, M.
2023Damage Trajectories in Systemic Sclerosis Using Group-Based Trajectory ModelingBarbacki, A.; Baron, M.; Wang, M.; Zhang, Y.; Stevens, W.; Sahhar, J.; Proudman, S.; Nikpour, M.; Man, A.; Australian Scleroderma Interest Group and the Canadian Scleroderma Research Group,

Discover